U.S. market Open. Closes in 6 hours 28 minutes

IMTXW | immatics biotechnologies GmbH Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
Revenue54.00M172.83M34.76M31.25M18.45M3.77M
Cost of Revenue118.66M106.78M87.57M67.08M40.09MN/A
Gross Profit-64.67M66.05M-52.81M-35.83M-21.64M3.77M
Operating Expenses155.72M142.88M121.05M100.97M51.46M38.18M
Selling, General & Admin38.20M36.12M33.81M34.19M11.76M7.67M
Research & Development118.66M106.78M87.57M67.08M40.09M33.97M
Other Operating Expenses-1.14M-26.00K-332.00K-303.00K-385.00K-3.46M
Operating Income-101.72M29.95M-86.29M-69.72M-33.01M-34.41M
Other Expenses / Income-8.28M12.08M-7.04M-159.90M526.00K1.56M
Before Tax Income-96.99M42.04M-93.33M-229.62M-32.49M-32.35M
Income Tax Expenses831.00K4.55M1.73M-268.00K-746.00K-2.96M
Net Income-96.99M37.51M-95.06M-229.35M-31.74M-31.44M
Interest Expenses831.00K8.28M1.73M289.00K170.00K16.00K
Basic Shares Outstanding80.55M67.22M62.91M48.00M62.91M62.91M
Diluted Shares Outstanding80.55M68.82M62.91M48.00M62.91M62.91M
EBITDA-80.65M46.34M-75.36M-64.44M-28.36M-31.73M
EBITDA Margin-149.35%26.81%-216.78%-206.19%-153.75%-841.54%
EBIT-95.33M50.34M-91.61M-229.33M-32.32M-34.39M
EBIT Margin-176.55%29.13%-263.52%-733.78%-175.17%-912.28%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙